What does DNAVision do?

DNAVision is a research organisation in Charleroi. Public Limited, started on 13 May 2004, 1 establishment.

What is the address of DNAVision?

The registered office of DNAVision is located at Avenue Georges Lemaitre 25, 6041 Charleroi.

Is DNAVision still active?

Yes. According to the CBE (29 October 2026) DNAVision is active, legal situation “Normale toestand”, started on 13 May 2004.

Is DNAVision registered on Peppol?

Yes, DNAVision is registered on the Peppol network with ID 0208:0865300475.

What is the enterprise number of DNAVision?

The enterprise number of DNAVision is BE0865300475.

When was DNAVision founded?

DNAVision was founded on 13 May 2004.

Who are the directors of DNAVision?

According to the 2025 annual accounts, the directors of DNAVision are: Laurent ALEXANDRE, Guy HELIN.

Is DNAVision a reliable company?

Databakkes does not pass judgement; this is what the sources say: Active according to the CBE since 13 May 2004; 5 annual accounts filed, latest fiscal year 2025; 2 directors known from the annual account.

How much profit did DNAVision make in 2025?

DNAVision recorded a loss after taxes of € 73,752 in financial year 2025.

What is the revenue of DNAVision?

As a small company, DNAVision is not required to publish revenue in its annual accounts. In financial year 2025, its added value was € -3,731.

How much does an employee at DNAVision earn?

The average wage cost per full-time employee at DNAVision was € 34,000 in 2025: staff costs of € 67,986 for 2 FTE, according to the annual account at the National Bank. That is the employer's cost, not net pay.

How many employees does DNAVision have?

According to the 2025 annual accounts, DNAVision has 2 full-time equivalents (FTE).

Does DNAVision have a website?

Yes, DNAVision has a website at dnavision.com.

DNAVision (Public Limited) - Charleroi - BE0865300475

Dossier DNAVision, printed on 29 October 2026 from databakkes.be/en/0865300475/dnavision. Sources: CBE, National Bank of Belgium, Belgian Official Gazette.

Warning lights

Signals from the annual accounts, the CBE and the Official Gazette, each with its threshold and source. No score, no verdict.

Negative equity NBB

More debt than assets in 4 of the last 4 fiscal years.
Two loss years in a row NBB

Negative result in 2024 and 2025.
Tight liquidity NBB

Cash and receivables cover 3 % of short-term debt in 2025; threshold 65 %.

Financials

Financial year 2025

DNAVision from Charleroi, company number BE0865300475, closed financial year 2025 with a result of € -73,752 after tax. For that financial year DNAVision recorded a gross margin of € -3,731 and equity of € -879,841. Compared with financial year 2024, the result moved from € -24,981 to € -73,752. The company made a loss. More debts than assets. High debts against a small own buffer. The most recent annual accounts were filed with the National Bank of Belgium on September 21, 2026.

What it is worth Caution

€ -879,841

▼ € 73,752 vs 2024

Assets minus debts, by the books. What is left if everything were sold and paid today.

Loss Caution

€ -73,752

▼ 195 % more loss than in 2024

Profit after tax over the fiscal year.

Cash in the bank

€ 19,451

▼ 59% vs 2024

Cash and bank balances on the last day of the fiscal year.

Where the profit goes Caution

Loss, nothing to pay out

Reserves fell to € -941,341.

People and assets in 2025

Full-time equivalents

Average over the fiscal year, from the social balance sheet.

Wage cost

€ 67,986

▲ 3% vs 2024

€ 34,000 per full-time equivalent. Payroll staff only. What the director pays themselves is already netted into the gross margin and is not shown separately in the accounts.

Debts at end 2025

Bank debt

None

No bank loans on the last day of the fiscal year.

Owed to suppliers

€ 6,312

▼ 19% vs 2024

Supplier invoices still open on the last day of the fiscal year.

Taxes and wages

€ 8,188

▲ 3% vs 2024

Taxes, VAT and social contributions still to pay.

Key figures per fiscal year Download key figures (CSV)
	2022	2023	2024	2025	Change 2024 → 2025
Gross margin	€ 38,699 Gross margin 2022: € 38,699 First fiscal year in the series	€ 38,257 Gross margin 2023: € 38,257 ▼ 1% vs 2022 (€ 38,699) Unfavourable step	€ 44,995 Gross margin 2024: € 44,995 ▲ 18% vs 2023 (€ 38,257) Favourable step	€ -3,731 Gross margin 2025: € -3,731 ▼ € 48,726 vs 2024 (€ 44,995) Unfavourable step	▼ € 48,726
Profit after taxes	€ -103,712 Profit after taxes 2022: € -103,712 First fiscal year in the series	€ -26,071 Profit after taxes 2023: € -26,071 ▲ € 77,641 vs 2022 (€ -103,712) Favourable step	€ -24,981 Profit after taxes 2024: € -24,981 ▲ € 1,091 vs 2023 (€ -26,071) Favourable step	€ -73,752 Profit after taxes 2025: € -73,752 ▼ € 48,771 vs 2024 (€ -24,981) Unfavourable step	▼ € 48,771
Equity	€ -755,038 Equity 2022: € -755,038 First fiscal year in the series	€ -781,109 Equity 2023: € -781,109 ▼ € 26,071 vs 2022 (€ -755,038) Unfavourable step	€ -806,089 Equity 2024: € -806,089 ▼ € 24,981 vs 2023 (€ -781,109) Unfavourable step	€ -879,841 Equity 2025: € -879,841 ▼ € 73,752 vs 2024 (€ -806,089) Unfavourable step	▼ € 73,752
Total debts	€ 820,423 Total debts 2022: € 820,423 First fiscal year in the series	€ 873,717 Total debts 2023: € 873,717 ▲ 6% vs 2022 (€ 820,423) Unfavourable step	€ 858,861 Total debts 2024: € 858,861 ▼ 2% vs 2023 (€ 873,717) Favourable step	€ 907,663 Total debts 2025: € 907,663 ▲ 6% vs 2024 (€ 858,861) Unfavourable step	▲ 6%
Cash	€ 11,835 Cash 2022: € 11,835 First fiscal year in the series	€ 82,803 Cash 2023: € 82,803 ▲ € 70,968 vs 2022 (€ 11,835) Favourable step	€ 47,396 Cash 2024: € 47,396 ▼ 43% vs 2023 (€ 82,803) Unfavourable step	€ 19,451 Cash 2025: € 19,451 ▼ 59% vs 2024 (€ 47,396) Unfavourable step	▼ 59%
Retained profit	€ -816,538 Retained profit 2022: € -816,538 First fiscal year in the series	€ -842,609 Retained profit 2023: € -842,609 ▼ € 26,071 vs 2022 (€ -816,538) Unfavourable step	€ -867,589 Retained profit 2024: € -867,589 ▼ € 24,981 vs 2023 (€ -842,609) Unfavourable step	€ -941,341 Retained profit 2025: € -941,341 ▼ € 73,752 vs 2024 (€ -867,589) Unfavourable step	▼ € 73,752
Balance sheet total	€ 65,386 Balance sheet total 2022: € 65,386 First fiscal year in the series	€ 92,608 Balance sheet total 2023: € 92,608 ▲ 42% vs 2022 (€ 65,386) Unchanged	€ 52,772 Balance sheet total 2024: € 52,772 ▼ 43% vs 2023 (€ 92,608) Unchanged	€ 27,822 Balance sheet total 2025: € 27,822 ▼ 47% vs 2024 (€ 52,772) Unchanged	▼ 47%
Employees (FTE)	4.6 Employees (FTE) 2022: 4.6 First fiscal year in the series	2 Employees (FTE) 2023: 2 ▼ 2.6 vs 2022 (4.6) Unchanged	2 Employees (FTE) 2024: 2 Unchanged (2) Unchanged	2 Employees (FTE) 2025: 2 Unchanged (2) Unchanged

Key figures of DNAVision, fiscal years 2022 to 2025, from the annual accounts filed with the National Bank of Belgium.Next annual account (fiscal year 2026) expected before 31 July 2027.

What happened to DNAVision?

What happened at DNAVision in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:

2028 Laurent ALEXANDRE stepped down as director. NBB
2028 Guy HELIN stepped down as director. NBB
Sep 21, 2026 New annual accounts for financial year 2025: loss of € 73,752. filed late Source: NBB ↗
2021 Laurent ALEXANDRE became a director. NBB
2021 Guy HELIN became a director. NBB
Sep 16, 2004 New establishment in Charleroi. KBO
May 13, 2004 Start of the company according to the CBE. KBO

In short

From € 103,712 loss in 2022 to € 73,752 loss in 2025.

Paid € 1,221 in corporate taxes since 2022.

On average € 22,500 of value added per employee in 2024.

Original PDFs at the National Bank ↗

Management

Directors

According to the 2025 annual accounts

Laurent ALEXANDRE

Managing director

since 2021 · until 2028

Guy HELIN

Director

Also active at: INTERNATIONAL PROFESSIONAL MANAGEMENT CONSULTANT BELGIQUE, SYNGULON, Pôle GREENWIN

since 2021 · until 2028

Establishments

Establishment units

Physical locations of this company

Registered office

Avenue Georges Lemaitre 25

6041 Charleroi

Who else lives here?

A building full of entrepreneurs or one very busy letterbox? Another 2 companies are registered at this address.

All companies at this address →

Institut de Pathologie et de Génétique

€ 53.2 million revenue · 2025

BIO.BE

€ 506,347 gross margin · 2025

What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.

Website

HTTPS dnavision.com

Canonical: https://www.dnavision.com

Technologies

Advanced Custom FieldsLodashPWAReactWixlazysizes

Hosting & Email

Email provider

Microsoft 365

Hosting

WIX_COM, IL

Domain

dnavision.com

Registered

2003-12-07

Registrar

OVH sas

Expires

2027-12-07

Website info

HTTPS Ja

Languages AF

Features

Webshop

Security

✓ HTTPS

✓ SPF

✗ DMARC

Network

✓ Load balancing

Details

Company number

0865.300.475

VAT number

BE 0865.300.475

Registered office

Avenue Georges Lemaitre 25, 6041 Charleroi

Names & denominations

DNAVision

Enterprise type

Rechtspersoon

Legal form

Public limited company

Legal situation

Normale toestand

Start date

13 May 2004

Peppol

Active · Active since 1 Jan 2001

Contact

dnavision.com 0032 71 34 78 80

Activities · NACE

Speur- en ontwikkelingswerk op biotechnologisch gebied

Overig speur- en ontwikkelingswerk op natuurwetenschappelijk gebied

Speur- en ontwikkelingswerk op natuurwetenschappelijk gebied